Spain Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others
- Published: October 2011
Translational Biomedicine is an open access journal publishing articles focusing on information derived from human experimentation so as to optimise the communication between basic and clinical science. The aim of the Translational Biomedicine is given on the inside cover of each copy of the Journal; we seek to improve the health of people in the developing world. The Journal fulfils this aim by publishing papers on a wide range of clinical topics as well as on the determinants and epidemiology of illnesses and researches.
How are decisions on publication made? Firstly, the paper needs to address the core objective of the journal described above. Secondly, methodology is very important; the publisher looks for high quality experimental and observational studies.
The publisher wants to see substantial clinical and public health questions addressed. Often, the best way to do this is by using an experimental study design. The randomised controlled trial continues to offer important strengths, addressing issues of confounding and reducing the risks of bias.
This publication aims to make this information widely available to doctors, nurses, other health workers and
READ MORE >
- A Balanced Trade Context for HIV Patent Pool
- Papillary cancer of the colon: a rare presentation with lower GI bleed and a review of the literature
- Effect of Pinus koraiensis seed oil on satiety hormones CCK and GLP-1 and appetite suppression
- Academic websites containing H1N1 swine flu information need to provide content on therapeutic options including vaccines and neuraminidase-inhibitors for pregnant women: Time for a Policy Statement on web site content
- Micronutrient Optimization Storage Trial Using Customized Vitamin & Mineral Replacement Therapy Most 2010
- First French-Argentine Immunology Congress, 2010 Abstracts Held on Buenos Aires, Argentina, 2nd-5th november, 2010
- Bone Marrow-derived Mononuclear Stem Cell Implantation
- Targeted weight reduction using Sibutramine.
- Targeted weight reduction using Sibutramine.
- CXCR4 inhibitor plerixafor and G-CSF allow for an effective peripheral blood stem cell collection in patients who failed previous mobilization attempt
- A Rare Presentation of Community-acquired Pneumonia Caused by Corynebacterium pseudodiptheriticum: A Case Report.
- Knowledge of female genital cutting among parents in south west Nigeria
- Kaposi Sarcoma Pathogenesis: A Triad of Viral Infection, Oncogenesis and Chronic Inflammation
- Possible correlation of plica-limbal distance with the presence of primary medial pterygium
- Rho Kinase-mediated Coronary Arteriolar Constriction to Endothelin-1: Mechanistic Implications for Cardiac Syndrome X
- The incidence of head and neck cancers in the Republic of Suriname Between the years 1980 and 2004.
- Phosphate buffer-stabilized 0.1% chlorine dioxide-containing mouth
- Needs-driven rather than market-driven rules to spread access to medicines in poor countries
- Estimation of Familial Association of Blood Pressure with BMI and WHR among Type 2 Diabetic and Non-diabetic Punjabi Population in Punjab, India
- A Review of Clinical Trials in Spain
- Translational Biomedicine: a clinician’s view
- Academic websites containing H1N1 swine flu information need to provide content on therapeutic options including vaccines and neuraminidase-inhibitors for pregnant women: Time for a Policy Statement on web site content
| Format | Properties | |
|---|---|---|
| Electronic (PDF) | The report will be emailed to you. The report is sent in PDF format. | This is a single user license, allowing one specific user access to the product. |
| Hard Copy (Hard Back) | A printed copy of the report will be shipped to you. The report has a hardback cover. | |
| Enterprisewide | The report will be emailed to you. The report is sent in PDF format. | This is an enterprise license, allowing all employees within your organisation access to the product. |